Brachytherapy

Papers
(The H4-Index of Brachytherapy is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement29
First clinical implementation of GammaTile permanent brain implants after FDA clearance28
Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas26
Education and training for image-guided adaptive brachytherapy for cervix cancer—The (GEC)-ESTRO/EMBRACE perspective24
Virtual reality-based simulation improves gynecologic brachytherapy proficiency, engagement, and trainee self-confidence24
Substantial lymphovascular space invasion predicts worse outcomes in early-stage endometrioid endometrial cancer22
Simulation-based learning for enhanced gynecologic brachytherapy training among radiation oncology residents20
Very accelerated partial breast irradiation Phase I–II multicenter trial (VAPBI): Feasibility and early results20
Increasing global access to brachytherapy: The ABS 300 in 10 initiative and ongoing international efforts20
Multimaterial three-dimensional printing in brachytherapy: Prototyping teaching tools for interstitial and intracavitary procedures in cervical cancers18
Development of a gynecologic brachytherapy curriculum and simulation modules to improve radiation oncology trainees’ skills and confidence18
Addressing the burden of cervical cancer through IAEA global brachytherapy initiatives17
Partial breast irradiation: An updated consensus statement from the American brachytherapy society16
Low-cost 3D print–based phantom fabrication to facilitate interstitial prostate brachytherapy training program16
Early outcomes after definitive chemoradiation therapy with Vienna/Venezia hybrid high-dose rate brachytherapy applicators for cervical cancer: A single-institution experience14
0.080744028091431